Medicus Pharma Ltd. (MDCX) News
Track canonical SquawkNews coverage tagged to MDCX, Medicus Pharma Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Medicus Pharma reports Q2 2026 results and corporate update
Medicus Pharma (MDCX) reports its second quarter 2026 financial results and provides a corporate update, with no additional figures included in the provided alert.
EARNINGS | Aug 12, 2026, 10:00 PM UTC
M
MDCX Appoints CEO of Antev Limited
MDCX appoints Dr. Faisal Mehmud as CEO
EQUITY | Aug 03, 2026, 11:30 AM UTC
H
UAE Grants Authorization
UAE authorizes phase 2a study
EQUITY | Jul 31, 2026, 11:30 AM UTC
H
MDCX Receives UAE Health Authorization
MDCX gets UAE approval for medicine study
EQUITY | Jul 31, 2026, 11:30 AM UTC
L
Medicus Pharma gets FDA green light for SkinJect Phase 2b Gorlin study
Medicus Pharma announced...
REGULATION | Jul 27, 2026, 01:10 PM UTC
L
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ: CRIS ) stock rose 9.0% to $0.46 during Wednesday's after-market session. The company's market cap stands at $20.3 million. Humacyte (NASDAQ: HUMA ) shares moved upwards by 5.45% to $0.71. The marke
EQUITY | Jul 01, 2026, 09:05 PM UTC